While pro-angiogenic variants, such as VEGF-A, are well studied for their role in facilitating tumor growth and metastasis by promoting the formation of new blood vessels, anti-angiogenic splice variants, represented by VEGF165b, provide a natural countermeasure by inhibiting these processes [39]. The gene discussed is VEGFA; the disease is neoplasm.